Results 101 to 110 of about 4,438 (134)

Variable treatment response to lumasiran in pediatric patients with primary hyperoxaluria type 1. [PDF]

Pediatr Nephrol
Saffe S, Doerry K, Büscher AK, Hansen M, Rohmann M, Kanzelmeyer N, Latta K, Kemper MJ, Loos S.   +8 more
europepmc   +1 more source

Effective Newborn Screening for Type 1 and 3 Primary Hyperoxaluria. [PDF]

Kidney Int Rep
Hoppe B, Martin-Higueras C, Borghese L, Kaspar S, Reusch B, Beck BB, Walli A, Janzen E, Hegert S, Janzen N, Hohenfellner K.   +10 more
europepmc   +1 more source

PHYOX3: Nedosiran Long-Term Safety and Efficacy in Patients With Primary Hyperoxaluria Type 1. [PDF]

Kidney Int Rep
Lieske JC, Ariceta G, Groothoff JW, Lipkin G, Moochhala SH, Schalk G, Sellier-Leclerc AL, Torres SE, Rawson V, Zhou J, Hoppe B.   +10 more
europepmc   +1 more source

A molecular journey on the pathogenesis of primary hyperoxaluria. [PDF]

Curr Opin Nephrol Hypertens
Cellini B.
europepmc   +1 more source

Primary hyperoxaluria type 1 diagnosis in adult dialysis patients: prediction model assessment in a group of Italian patients. [PDF]

J Nephrol
Ferraro PM, Arbustini E, Bellino D, Caletti C, Capelli I, Capolongo G, Caruso MR, Cianfrone P, D'Alessandro MM, Di Luca M, Gambaro G, Palmisano A, Ranghino A, Santagostino Barbone G, Viazzi F, Zambianchi L, Mandrile G.   +16 more
europepmc   +1 more source

Primary Hyperoxaluria With Cardiac Involvement: A Case Series. [PDF]

Arq Bras Cardiol
Ávila DX, Molin CZD, Barbosa Júnior JDS, Carvalho LC, Rocha JP, Moura MJH, Grüdtner DOM, Bittencourt R.   +7 more
europepmc   +1 more source

Population Pharmacokinetic and Pharmacodynamic Modelling and Simulation for Nedosiran Clinical Development and Dose Guidance in Pediatric Patients with Primary Hyperoxaluria Type 1. [PDF]

Clin Pharmacokinet
Zhang S, Gamallo P, Rawson V.
europepmc   +1 more source

Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease. [PDF]

Sci Adv
Yang T, Ge J, Huang L, Zhu X, Zhang D, Tang S, Zhao J, Ma Y, Long M, Bo X, Li J, Zhang Y, Yuan Q, Sharma AD, Ott M, Geng H, Zhao Y, Zhang L, Shen H, Li H, Li D, Wan P, Xia Q.   +22 more
europepmc   +1 more source

Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1. [PDF]

J Biol Chem
Gatticchi L, Bellezza I, Rumsby G, Glover M, Cellini B.   +4 more
europepmc   +1 more source